Lamictal 5mg dispersible tablets

Страна: Велика Британія

мова: англійська

Джерело: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активний інгредієнт:

Lamotrigine

Доступна з:

GlaxoSmithKline UK Ltd

Код атс:

N03AX09

ІПН (Міжнародна Ім'я):

Lamotrigine

Дозування:

5mg

Фармацевтична форма:

Dispersible tablet

Адміністрація маршрут:

Oral

Клас:

No Controlled Drug Status

Тип рецепту:

Valid as a prescribable product

Огляд продуктів:

BNF: 04080100; GTIN: 5010706004900 05000123115709

інформаційний буклет

PACKAGE LEAFLET: INFORMATION FOR THE USER
LAMICTAL
®
2 MG, 5 MG, 25 MG AND 100 MG
CHEWABLE/DISPERSIBLE TABLETS
LAMOTRIGINE
LAMICTAL
®
2 MG, 5 MG, 25 MG AND 100 MG CHEWABLE/DISPERSIBLE TABLETS
LAMOTRIGINE
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU
.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their
signs of illness are the same as yours.
If you get any of the side effects, talk to your doctor or pharmacist.
This includes any possible side effects
not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1
WHAT LAMICTAL IS AND WHAT IT IS USED FOR
2
WHAT YOU NEED TO KNOW
B
EFORE YOU TAKE LAMICTAL
3
HOW TO TAKE LAMICTAL
4
POSSIBLE SIDE EFFECTS
5
HOW TO STORE LAMICTAL
6
CONTENTS OF THE PACK AND OTHER INFORMATION
OTHER FORMATS
To listen to or request a copy of this leaflet in Braille, large print
or audio please call, free of charge:
0800 198 5000 (UK only)
Please be ready to give the following information:
PRODUCT NAME
LAMICTAL 2 MG CHEWABLE/DISPERSIBLE TABLETS
LAMICTAL 5 MG CHEWABLE/DISPERSIBLE TABLETS
LAMICTAL 25 MG CHEWABLE/DISPERSIBLE TABLETS
LAMICTAL 100 MG CHEWABLE/DISPERSIBLE TABLETS
Reference number
00003/0375
This is a service provided by the Royal National Institute of Blind
People.
1
1
WHAT LAMICTAL IS AND WHAT IT IS USED FOR
Lamictal belongs to a group of medicines called
_anti-epileptics_
. It is used to treat two conditions -
EPILEPSY
and
BIPOLAR DISORDER
.
LAMICTAL TREATS EPILEPSY
by blocking the signals in the brain that trigger epileptic seizures
(fits)
•
For adults and children aged 13 years and over, Lamictal can be used
on its own or with other
medicines, to treat epilepsy. Lamictal can also be used with other
medicines to treat the seizures that
occur with a condition called Lennox-Gastaut syndrome.
•
For children aged between 2 and

Характеристики продукта

PRODUCT SUMMARY
1.
NAME OF THE MEDICINAL PRODUCT
Not applicable
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Not applicable
3.
PHARMACEUTICAL FORM
Not applicable
4.
CLINICAL PARTICULARS
4.1.
THERAPEUTIC INDICATIONS
Not applicable
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
Not applicable
4.3.
CONTRAINDICATIONS
Not applicable
4.4.
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Not applicable
4.5.
INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
Not applicable
4.6.
PREGNANCY AND LACTATION
Not applicable
4.7.
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
Not applicable
4.8.
UNDESIRABLE EFFECTS
Not applicable
4.9.
OVERDOSE
Not applicable
5.
PHARMACOLOGICAL PROPERTIES
5.1.
PHARMACODYNAMIC PROPERTIES
Not applicable
5.2.
PHARMACOKINETIC PROPERTIES
Not applicable
5.3.
PRECLINICAL SAFETY DATA
Not applicable
6.
PHARMACEUTICAL PARTICULARS
6.1.
LIST OF EXCIPIENTS
Not applicable
6.2.
INCOMPATIBILITIES
Not applicable
6.3.
SHELF LIFE
Not applicable
6.4.
SPECIAL PRECAUTIONS FOR STORAGE
Not applicable
6.5.
NATURE AND CONTENTS OF CONTAINER
Not applicable
6.6.
INSTRUCTION FOR USE AND HANDLING (, AND DISPOSAL)
Not applicable
No Data Held
ADMINISTRATIVE DATA
7.
MARKETING AUTHORISATION HOLDER
Not applicable
8.
MARKETING AUTHORISATION NUMBER
Not applicable
9.
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
Not applicable
10.
DATE OF REVISION OF THE TEXT
Not applicable